Telehealth Compliance for Payments: Navigating HIPAA, DEA, and State Regulations

Telehealth platforms operate at the intersection of healthcare regulation, federal drug law, and state-by-state licensure — creating a payment compliance environment more complex than almost any other industry. Getting payments right for telehealth means understanding not just payment processor requirements, but how HIPAA, DEA scheduling, and state telehealth laws affect what your platform can process and how.

HIPAA and Payment Processing

HIPAA (the Health Insurance Portability and Accountability Act) applies to covered entities — healthcare providers, health plans, and healthcare clearinghouses — and their business associates. For telehealth platforms, payment processing creates specific HIPAA considerations:

• Payment processor as business associate: If your payment processor has access to Protected Health Information (PHI) in connection with payment processing, a Business Associate Agreement (BAA) is required. Most payment processors operate in ways that minimize PHI exposure (processing only financial data), but if your platform architecture routes clinical data through the payment flow, a BAA must be in place.
• PCI DSS and HIPAA intersection: Payment card data and PHI are governed by separate compliance frameworks. Telehealth platforms must maintain both PCI DSS compliance (for payment data) and HIPAA compliance (for health data) — they don’t substitute for each other.
• Explanation of Benefits (EOB): If billing insurance, EOB data is PHI and requires appropriate protection.

DEA Scheduling and Payment Implications

The DEA’s regulations on controlled substance prescribing via telehealth — particularly the Ryan Haight Act and its COVID-era emergency exceptions — affect what telehealth platforms can prescribe and how. Payment processors care about DEA compliance for telehealth platforms prescribing controlled substances because:

• Platforms operating outside DEA authorization for controlled substance prescribing are in violation of federal law — a significant card network compliance risk
• Some payment processors won’t process for platforms that prescribe Schedule II or III substances via telehealth without demonstrated compliance infrastructure

State Telehealth Licensure

Telehealth platform compliance varies significantly by state: prescribing authority, required disclosures, synchronous vs. asynchronous care requirements, and patient-provider relationship rules differ across jurisdictions. Payment processors evaluating telehealth merchants typically look for evidence of state-by-state licensure coverage — or a clear scope limitation to states where the platform is authorized.

What Payment Processors Need from Telehealth Platforms

For underwriting purposes, telehealth platforms typically need to provide: evidence of practitioner licensure in served states, DEA registration (if prescribing controlled substances), HIPAA compliance documentation, and clear descriptions of the services being billed and the clinical scope of the platform.

ConvesioPay for Telehealth

ConvesioPay provides dedicated underwriting review for telehealth platforms — evaluating compliance documentation, service scope, and risk profile with a human account manager rather than an automated system. Each application is reviewed on its merits. Pricing: 2.9% + $0.30, no monthly fees.